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ABSTRACT
Aortic stenosis is a cardiovascular disease affecting 2 to 4% of U.S. adults over
age 65 years old (Freeman & Otto, 2006). Aortic stenosis causes angina and syncope
eventually leading to heart failure and death (Otto, 2006). Transcatheter aortic valve
implantation (TAVI) is an alternative to surgical aortic valve replacement in patients with
high surgical mortality risk (Kappetein, 2013). The TAVI is associated with increased
cerebral injury, with silent ischemia reported in up to 90% of TAVI patients (Samim et
al., 2015). The present study examines the relationship between cerebral injury, cognitive
changes, and quality of life in TAVI patients.
Participants (n = 40) completed a cognitive assessment one day before the TAVI
and at one-month post-TAVI. The primary cognitive measure was the Repeatable Battery
for the Assessment of Neuropsychological Status (RBANS). Additional tests (letter
fluency, Trail Making Test, Digit Span Backward and Stroop) were included as measures
of executive function and working memory. Measures of functional ability (Physical
Self-Maintenance Questionnaire, Functional Activities Questionnaire, Dementia Severity
Rating Scale), mood (GDS), and quality of life (Kansas City Cardiomyopathy
Questionnaire) were also included. Baseline and follow-up MRIs were completed for 22
participants. Baseline RBANS Total Index scores (M = 85.26, SD = 14.69) evidenced
mild cognitive decline prior to the TAVI. At one month, there was significant
improvement on RBANS Language Index (p = 0.014), RBANS Fluency (p = 0.023),
RBANS Figure Recall (p = 0.027), GDS (p = 0.018), and KCCQ (p < 0.001). There was a
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significant decline on RBANS List Recall (p = 0.001). Six participants (27%) obtained
new cerebral lesions at one month. Participants with neuronal injury did not differ from
those without at one month (RBANS Total Score, p = 0.45).
TAVI is related to overall stable cognitive performance and improved quality of
life. The relationship between cerebral ischemia following TAVI and negative cognitive
consequences is not supported. Further research is required in the cognitive implications
following TAVI.
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CHAPTER I
INTRODUCTION
Cardiovascular Disease and Cognition
The relationship between cardiovascular disease and cognitive function is well
established in previous literature (Katzel & Waldstein, 2001). Cardiovascular disease
(CVD) is a broad term encompassing diseases of the heart, blood vessels, and circulation
(Katzel & Waldstein, 2001). CVD accounts for the most deaths in the United States per
year than any other cause. Stroke, often resulting from CVD, is the third highest cause of
death in the United States (Katzel & Waldstein, 2001).
CVD is related to cognitive decline in older adults (Katzel & Waldstein, 2001).
For example, hypertension, a predecessor to more serious CVDs, has been shown to
negatively affect cognitive function. Hypertension (i.e., systolic blood pressure ≥140
millimeters of mercury (mmHg) and/or diastolic blood pressure ≥90 mmHg) is a risk
factor for coronary artery disease, and atherogenesis (i.e., the deposit of plaque
particularly on the inner arterial wall) (Waldstein & Katzel, 2001). Longitudinal studies
have found that long-term hypertension is related to poorer performance on attention and
memory tasks in older adults, and hypertension predicts decline on Wechsler Adult
Intelligence Scale visuospatial subtests (Picture Completion, Picture Arrangement, Block
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Design, and Object Assembly) and speed subtests (Digit Symbol Substitution) (Elias

Robbins, Elias, & Streeten, 1998). Additional longitudinal studies show that midlife
hypertension predicted decline on tests of mental status and cognitive flexibility
(Waldstein & Katzel, 2001). The relationship between CVD and cognitive decline may
also have bidirectional negative consequences. Cognitive decline is a predictor of all
cause mortality after hospitalization in adults greater than 70 years old with
cardiovascular disease (Farid et al., 2013).
Atherosclerosis is arterial narrowing caused by the accumulation of fatty deposits
and fibrous tissue in the vessel wall (Everson, Helkala, Kaplan, & Salonen, 2001).
Fibrous plaques may become calcified, which decreases vessel flexibility and increases
frailty. Severe complications as a result of atherosclerosis include stroke, ischemia (i.e.,
areas of restricted blood flow), and heart attack. Carotid atherosclerosis has been shown
to result in poorer cognitive functioning in global cognition, nonverbal memory,
cognitive flexibility, verbal fluency, and verbal memory (Everson, Helkala, Kaplan, &
Salonen, 2001).
Hypoperfusion–lack of adequate blood flow and oxygen to the brain–is often
cited as the causal link between CVD and decreased cognitive abilities (Jefferson,
Poppas, Paul, & Cohen, 2007). Jefferson and colleagues (2007) examined the relationship
between neuropsychological functioning and cardiac output. Seventy-two participants
(mean age = 69.14) completed a neuropsychological battery and an echocardiogram. Data
from the echocardiogram was used to estimate cardiac output, which is the amount of
blood pumped from the heart to the systemic vascular system per minute (Jefferson et al.,
2007). When the participants were grouped based on cardiac output (low versus normal),
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the low cardiac output group performed worse on executive measures (DKEFS Tower
Test and DKEFS Trail Making Test) (Jefferson et al., 2007). Increased cerebral perfusion
following stenting in the carotid artery significantly predicts cognitive improvement
based on the informant behavioral observations in the Informant Questionnaire on the
Cognitive Decline in the Elderly (IQ-CODE; Moftakhar, Turk, Niemann, et al., 2005).
The IQ-CODE has been shown to correlate with Mini-Mental State examination and
episodic memory (Moftakhar et al., 2005).
Cardiovascular Disease Treatment and Cognition
In addition to CVD alone, treatment of CVD may have cognitive implications.
Coronary artery bypass grafting (CABG) is a surgical procedure to treat coronary artery
disease (CAD), which is caused by progressive narrowing to eventual occlusion in the
coronary arteries by artherosclerotic plaque (Newman, Stygall, & Kong, 2001). Studies
have found neuropsychological deficits following CABG in the following cognitive
domains: memory, attention, visuospatial, language, visuomotor, executive function, and
global functioning (Newman, Stygall & Kong, 2001). Cognitive changes following
CABG are often inconsistent with each study showing decline in different cognitive
domains, and these discrepancies are likely due to differing methodologies. Studies with
post testing evaluations within days following the surgery may be measuring
confounding factors such as postoperative recovery from anesthesia and surgery
(Newman, Stygall & Kong, 2001). Mahanna et al. (1996) assessed cognitive functioning
in 232 coronary artery bypass patients 6 days post-surgery and found decline (i.e., a
decrease of 20% from baseline on at least 20% of the measures) in 66% of patients. In the
same study, 34% continued to show cognitive impairment at 6 weeks and 19.4%
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continued at the 6-month follow-up. Studies with postoperative evaluations weeks or
months following the procedure measure more stable neuropsychological decline. For
example, Sellman, Holm, Ivert, and Semb (1993) assessed cognitive functioning 4 weeks
post-surgery in 54 coronary artery bypass surgery patients, and the researchers found
cognitive decline in 17% of the patients. In the same study, cognitive decline was stable
for 7% of the patients at a 6-month follow-up. Even with similar methodologies and
testing intervals, results are still variable in studies examining neuropsychological
functioning after cardiac surgery. However, research indicates that risk factors for
postoperative decline following CABG include increased age, female gender, and
increased severity of cardiac disease (Newman, Stygall, & Kong, 2001).
TAVI Procedure and Cerebral Injury
One type of CVD in the older adult population is aortic stenosis. Aortic stenosis is
narrowing of the aortic valve, which is located between the heart's left ventricle and the
aorta, and may result in backed up blood flow and increased pressure in the heart (Otto,
2006). Aortic stenosis results from a disease process of lipid accumulation, inflammation,
and calcification (Otto, 2006). Aortic sclerosis (i.e., thickening and hardening of the
aortic valve and precursor to stenosis) is found in approximately 2% of people age 65-74
years and approximately 48% in people over 84 years old (Freeman & Otto, 2005). The
risk of developing aortic stenosis increases with age with 2-4% of adults over the age of
65 meeting diagnostic criteria (Freeman & Otto, 2005). The disease ranges in severity,
but those with severe symptomatic aortic stenosis experience angina (i.e., chest pain),
syncope (i.e., fainting resulting from a fall in blood pressure), and heart failure (Otto,
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2006). Aortic stenosis is typically treated through surgical aortic valve replacement (open
heart surgery).
Transcatheter aortic valve implantation (TAVI) is a recently-developed procedure
to treat high-grade aortic stenosis in patients with risk factors that preclude the patients
from conventional aortic valve replacement (AVR) surgery. To qualify for TAVI,
patients must be denied surgical aortic valve replacement by two independent surgeons
based on mortality risk (Kappetein et al., 2013). The European System for Cardiac
Operative Risk Evaluation (EuroSCORE) and/or The Society for Thoracic Surgeons' risk
score (STS score) are used as assessments to evaluate patient mortality risk prior to the
procedure. The EuroSCORE includes patient factors (e.g., age, sex, history of chronic
pulmonary diseases, etc.), cardiac factors (e.g., unstable angina, recent myocardial
infarct, etc), and operation factors (e.g., level of emergency, additional cardiac
procedures performed in conjunction, etc.). A high mortality risk as assessed by the
EuroSCORE and other risk factors including liver disease, frailty, and severe pulmonary
hypertension (Kappetein et al., 2013) are combined with the cardiac surgeon's clinical
judgment to decide the patient's candidacy for surgical AVR. The STS score contains
multiple risk factors including, but not limited to morbid obesity, prior cardiac
conditions, medical conditions (e.g., diabetes, chronic pulmonary obstructive disease,
etc.), and type of procedure to predict mortality (Collas, Chong, Rodrigus, Vandewoude,
& Bosmans, 2015). Predicting mortality for TAVI patients is difficult, and the STS-score
is slightly more accurate in predicting two year mortality in high-risk patients than the
EuroSCORE (Collas et al., 2015).
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TAVI clinical trials have shown promising results in long-term success with

patients (Ussia, Barbanti, Petronio, et al., 2012; Toggweiler et al., 2013). However,
compared to AVR, TAVI is associated with higher rates of clinically significant stroke
(i.e., cerebral injury that results in overt changes in neurological function) (Hauville, BenDor, Lindsay, Pichard, & Waksman, 2012). Studies examining neurological injury
following cardiac procedures show clinically significant stroke following AVR ranges
from 0.7% to 5% while stroke following the TAVI procedure ranges from 0% to 10%
(Hauville et al., 2012).
Neurological injury (i.e., any number of central nervous system (CNS) injuries,
including encephalopathy, stroke, coma, delirium, and neurocognitive decline) is a
common concern following any cardiac surgery, particularly in older adults with
comorbid risk factors (Newman et al., 2006). TAVI candidates are typically older adults
with multiple risk factors, which resulted in their ineligibility for AVR. Even mild CNS
injury following cardiac surgery relates to decreased quality of life and cognitive abilities
(Newman et al., 2001), and it is associated with increased medical costs (Roach et al.,
1996). Previous research identifies a number of risk factors associated with increased
major stroke, higher rates of major cardiac or cerebral events, and mortality in TAVI
patients. See Table 1 for a list of medical variables that previous studies have associated
with CNS injury and cardiac surgery/TAVI.
The increased neurologic injury from TAVI has been associated with increased
emboli from the procedure (Arnold et al., 2010). Emboli may include air bubbles, fatty
deposits, blood clots, or another object that causes blood flow obstruction. In addition to
clinically significant stroke (see above), TAVI may have increased rates of clinically

6	
  

	
  

	
  

Table 1.
Medical variables and associated risks for neurological injury or death
Variable
Associated Risk
Reference
Age
Stroke following cardiac
Unstable angina
surgery
Diabetes (type I or II and insulin use)
History of neurological disease
Previous coronary artery bypass
surgery
History of vascular disease, history
of Pulmonary disease

Newman et al.
2006

Atrial Fibrillation

Stroke and Transient
Ischemic Attacks
following cardiac surgery

Creswell, 1999

Cerebrovascular disease
History of coronary artery disease
Higher transvalvular aortic gradient
Gender (male)
Hyperlipidemia
Renal dysfunction
Porcelain aorta
Increased left atrial appendage
velocity Lower aortic atheroma
thickness
Reduced aortic valve area

Silent Ischemia following
TAVI

Kahlert et al., 2010
Rodes-Cabau et al.,
2011
Tay et al., 2011

Increased creatine levels
Higher EuroSCORE

Mortality following TAVI

Codner et al., 2013

Left ventricular function (ejection
fraction <30%)
Moderate/severe aortic regurgitation
History of COPD

Mortality following TAVI

Moat et al., 2011

silent cerebral injury. Cerebral injuries that occur in the absence of specific neurological
dysfunction are considered clinically silent; clinically-silent cerebral injuries are only
detected through neuroimaging (Hauville et al, 2012). Neuroimaging techniques identify
areas of restricted blood flow known as ischemia. Persistent ischemia may lead to
7	
  

	
  

	
  

infarcts, which are permanent areas of dead tissue in the brain. Both ischemia and infarcts
can be clinically-apparent and clinically-silent cerebral injuries depending on the location
of the lesion.
Diffusion-weighted magnetic resonance imaging (DW-MRI) is an imaging
technique that is more sensitive to detecting ischemia than the standard MRI (Hauville et
al, 2012). The relationship between detected ischemia and true neuronal damage is
unclear (Bendszus & Stoll, 2006). Some studies have shown initial ischemic lesions
persisted to structural damage at later testing times while other studies have shown
lesions on DW-MRI cease without neuronal damage due to resolution of the restricted
blood flow. The discrepancies in results are likely due to different times the imaging was
completed. Overall, ischemia on DW-MRI that is present more than 24 hours after the
initial event are indicative of cerebral infarction (i.e., tissue death due to obstructed blood
supply) (Bendszus & Stoll, 2006).
Cerebral Ischemia and Cognitive Function
Studies examining the relationship between silent cerebral ischemia and cognitive
functioning have shown small or no effects (Bendszus & Stoll, 2006). Many studies only
include measures of global cognitive function (i.e., Mini-Mental State Examination) as
measurements of cognitive deficit and more nuanced changes in cognitive areas such as
processing speed and mood may be missed (Bendszus & Stoll, 2006).
Studies including more comprehensive cognitive measures show mixed results for
effects of lesions detected on DW-MRI. Knipp et al. (2005) administered a
neuropsychological battery assessing seven cognitive domains to 39 coronary artery
bypass graft surgery patients at baseline, at discharge, and at a three-month follow-up. At
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discharge, patients exhibited cognitive decline in all domains compared to pretest
performance. At the 3 month follow-up cognitive function was regained in all domains,
except immediate recall during a verbal learning task, which remained significantly
below baseline. Twenty patients (51%) evidenced new ischemic lesions following the
procedure. Those with ischemia were no more likely to have persistent cognitive decline
at the 3-month follow-up than patients without new lesions (n = 19). The ischemic injury
did not account for the cognitive decline in the study's sample.
Conversely, Restrepo et al. (2002) found that patients with new lesions on DWMRI had significantly larger declines on neuropsychological tests of psychomotor speed,
language, and visuospatial abilities than patients without new lesions. Restrepo et al.
(2002) used pre and post-neuroimaging and cognitive assessment in patients undergoing
coronary artery bypass grafting surgery. The cognitive assessment was completed within
a week prior to the procedure and within a week after the procedure. The assessment
included trail making test B (processing speed), oral and written naming tests, oral
reading tests (language), line cancellation, and Bells tests (visuospatial). Thirteen patients
completed both the pre and postoperative assessments. Ten patients experienced
cognitive decline in at least one test (7 demonstrated decline on one test, 2 patients
showed decline in >1 test, and 1 patient showed decline on 5 tests). Four patients showed
new diffusion lesions in the postoperative neuroimages, and patients with new lesions on
DW-MRI had greater decline (i.e., larger z-score change) between pre and postoperative
cognitive assessments than patients without new lesions (Restrepo et al., 2002). In
comparison to Knipp et al. (2005), the time of post-procedural cognitive evaluations may
explain the discrepancy in results. Restrepo et al. (2002) completed the follow-up
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cognitive evaluation within one week following the procedure while Knipp et al. (2005)
had a 3-month follow-up examination. Ischemic lesions may relate to cognitive decline
shortly following the cardiac procedure (as found in Restrepo et al., 2002), but the
cognitive impact of ischemic lesions could be reduced over time (as found in Knipp et al.,
2005). Additionally, surgical effects such as recovery from anesthesia may confound
cognitive testing within days following a surgical procedure (Newman, Stygall & Kong,
2001). Ischemic lesions are only one factor to consider when examining cognitive
performance following a cardiac procedure.
In patients undergoing a coronary artery bypass grafting (CABG) with on-pump
procedure (i.e., a heart-lung artificial circulation system is used and the heart is stopped),
ischemic lesions were associated with cognitive dysfunction (Lund et al., 2005).
However, ischemic changes were not associated with cognitive decline in patients
undergoing the procedure off-pump (i.e., the heart continues beating) (Lund et al., 2005).
One hundred six patients were given a neuropsychological evaluation preoperatively, at a
3-month follow-up, and at a 1-year follow-up. Patients were given 10 tests measuring six
cognitive domains: Grooved pegboard (motor coordination), Digit Symbol, Trail Making
Test (psychomotor speed), Digit Span, Stroop Color-Word Interference Test (attention),
Rey Auditory Verbal Learning, Rey Auditory Verbal Learning Recall (verbal memory),
Similarities, Controlled Oral Word Association Test (verbal comprehension and fluency),
Block Design (visuoconstructive abilities). Eleven of the 54 off-pump patients and 12 of
52 on-pump patients demonstrated cognitive decline at 3 months (Lund et al., 2005).
After one year, 13 of the 54 off-pump and 12 of the 52 on-pump patients had continued
cognitive impairment. Neuroimaging revealed new ischemic lesions in 13 (12.5%; 9 on-
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pump; 4 off-pump) of the patients. New ischemic changes were not associated with
cognitive decline in either group, but preoperative MRI classification (i.e., normal,
borderline, pathologic) was significantly correlated with cognitive decline for the onpump patients. Preoperative MRI classifications were normal when no cerebral lesions
were present, borderline when cerebral lesions were < 5mm, and pathologic when
cerebral lesions were >5mm. No patients with normal preoperative MRI had cognitive
impairment at 3 months. Twenty percent of patients with borderline preoperative MRI
and 27.1% with pathologic preoperative MRI had cognitive decline at 3 months (Lund et
al., 2005). The authors state that prior cerebral lesions may result in fewer cognitive
resources and a greater susceptibility to negative consequences from ischemia occurring
from the procedure.
In another study using coronary artery bypass grafting (CABG) patients, new
ischemic lesions were not associated with postoperative cognitive decline (Bendszus et
al., 2002). Bendszus and colleagues (2002) administered the d2-letter cancellation test
(sustained attention and concentration), Benton Visual retention test (visual short-term
memory and visuomotor), Reitan trail-making test A (attention, psychomotor tracking
speed, and motor coordination) at 2 days pre-procedure and 3, 6, and 9 days post-surgery.
Nine of 35 patients (26%) exhibited new ischemic lesions following CABG. Patients with
prior diffuse white matter changes noted in the preprocedural MRI were more likely to
experience new ischemic lesions. There was no relationship between new lesions and
neuropsychological test performance at the 3-day follow-up (Bendszus et al., 2002).
Instead of new ischemic lesions, overall neuronal loss (combined pre- and post-CABG
neuronal damage) may account for cognitive changes. The researchers used the
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biomarker N-Acetylaspartate to indirectly measure neuronal injury. N-Acetylaspartate is
found exclusively in neuronal tissue, and decreased levels are associated with neuronal
loss or impaired functioning in neurons. The authors found decreased N-Acetylaspartatecreatine ratios were associated with decreased performance on the letter cancellation test,
Reitan Trail Making A, and Benton visual retention tasks 3 days postprecedure
(Bendszus et al., 2002). When the N-Acetylaspartate-creatine levels returned to baseline
10-14 days postoperatively, neuropsychological functioning also returned to baseline.
TAVI, Cerebral Injury, and Cognition
Understanding the cognitive impact of silent ischemia is an important aspect in
the TAVI procedure as TAVI patients have a high occurrence of ischemia. DW-MRI
studies have found silent ischemic changes in 68% to 90% of TAVI patients, but many
studies have not extensively examined cognitive sequelae from these ischemic changes
(Rodes-Cabau, Dumont, Boone et al., 2011; Kahlert et al., 2010; Samim et al., 2015).
Compared to the standard surgical AVR, the TAVI procedure is associated with higher
occurrence of lesions detected by DW-MRI. The observed DW-MRI lesion rate for
surgical AVR ranges from 38% to 47% (Spaziano et al., 2014).
Rodes-Cabau and colleagues (2011) examined the difference in cerebral injury in
patients following transapical (TA) TAVI (n = 31) and transfemoral (TF) TAVI (n = 29)
procedures. TA-TAVI and TF-TAVI differ in the artery routes taken to access the aortic
valve. TF-TAVI is a more commonly used TAVI approach, in which a valve-containing
catheter is advanced through the femoral artery and through the aortic arch. The TATAVI procedure is used for patients with calcified, diseased, or too small arteries, and
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consists of avoiding the aortic arch by advancing the catheter through the ventricular
apex located at the bottom of the ventricle, inferior to the aortic valve.
DW-MRIs were obtained within 24 hours prior to the TAVI procedure and within
6 days following the procedure (Rodes-Cabau et al., 2011). Sixty patients completed the
Mini-Mental State Examination (MMSE) and the National Institutes of Health Stroke
Scale (NIHSS). The MMSE is a brief global cognitive function screening that measures
several cognitive areas: orientation to place and time, memory registration, attention,
memory recall, language, complex commands, and visuospatial ability (Folstein, Folstein,
& McHugh, 1975). The NIHSS is a 15-item scale measuring neurological functioning
including vision, gaze, level of consciousness, language, sensory loss, dysarthria, facial
palsy, extreme weakness, and ataxia (Brott et al., 1989). Pre-procedural DW-MRI results
indicated that prior to the procedure, no previous acute ischemic lesions were found, and
old silent ischemic lesions were found in 53% of the patients (Rodes-Cabau et al., 2011).
Post-procedure imaging results revealed 68% of patients had new ischemic lesions, and
most patients with new lesions had multiple lesions sites. The new lesions occurred in
both hemispheres (73%) and in anterior and posterior vascular territories (66%). There
were no differences between the TA and TF in number or location of new ischemic
lesions. New lesions were found more frequently in patients that had a history of
coronary artery disease, that exhibited a higher transvalvular aortic gradient (pressure
gradient surrounding the aortic valve), and that were male. There were no significant
differences in neurological function as assessed by the NIHSS between pre- and postprocedure evaluations for both patients with ischemic lesions and those without. No
significant differences were found in cognitive function at baseline (MMSE median = 28,
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range 16-30) compared to after the procedure (MMSE median = 28, range 17-30, p =
0.14). No differences in cognitive function were found between patients without new
lesions compared to those with new lesions (p = 0.90) (Rodes-Cabau et al., 2011).
Compared to Rodes-Cabau et al. (2011) who found 68% of TAVI patients had
new ischemic diffusions on DW-MRI, Kahlert et al. (2010) found 86% of TAVI patients
had new ischemic lesions. Kahlert and colleagues (2010) compared imaging and
neurological function of patients undergoing a transfemoral TAVI procedure to surgical
aortic valve replacement. Neurological function was evaluated using the NIHSS, and
cognitive function was assessed with the MMSE at baseline and post-procedure (2.5 to
4.4 days). No statistically significance differences were found between baseline MMSE
(M = 28.4, range = 27.4 to 29.3) and post-procedure MMSE (M = 28.2, range = 27.3 to
29.1). No significant changes occurred in NIHSS scores between pre and postoperative
measurements. Restricted diffusions were found in 86% (19 of 22) of TAVI patients and
80% of surgical aortic valve replacement (8 of 10) patients. A three-month follow-up
DW-MRI showed no new restricted diffusion foci beyond lesions initially detected at the
postoperative evaluation. Additionally, at the three-month follow-up, NIHSS and MMSE
scores remained similar to baseline. Patient risk factors for new foci included
hyperlipidemia, renal dysfunction, porcelain aorta, increased left atrial appendage
velocity, lower aortic atheroma thickness, and reduced aortic valve area at baseline
(Kahlert et al., 2010).
Arnold and colleagues (2010) examined silent ischemia following TA-TAVI
procedures. Twenty-five patients completed the pre (6±12 days before) and post
procedural (6±2 days after) MRI examinations. Seventeen (68%) of the patients showed
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new focal diffusion abnormalities. Five of the 17 with new lesions exhibited neurological
changes caused by new lesions (Arnold et al., 2010). Neurological changes included
reduced awareness (one patient), transitive diplopia (one patient), and transitive psychosis
(three patients) (Arnold et al., 2010). Cognitive function was not assessed in the study. In
a more recent study, ischemic lesions were found in 90% of patients five days post-TAVI
(Samim et al., 2015). Significant predictors for new ischemia were age, hyperlipdemia,
and dilation of the implant. Samim and colleagues (2015) did not examine cognitive
changes.
Another study found few negative neurological effects immediately following and
at a long-term follow-up after a TF-TAVI procedure (Ghanem et al., 2010). Patients
completed pre and two post-procedural DW-MRI examinations. The second examination
occurred 2.2 ± 0.4, and the third examination occurred 91 ± 5 days after the TAVI
procedure. Sixteen patients (72.7%) showed new ischemic lesions, of which, only three
patients had ischemia at the second examination that persisted to focal infracted brain
tissue at the third examination. Only one patient had persistent neurological deficits at the
third examination (NIHSS = 16). Two patients exhibited neurological deficits at the
second examination, but not the third examination. These transient neurological
symptoms were not correlated with DW-MRI lesions (Ghanem et al., 2010).
The above research indicates that silent ischemia from the TAVI procedure may
not have a negative impact on neurological function (i.e., as assessed by the NIHSS) and
global cognitive function (i.e., as assessed by the MMSE). Overall, the majority of TAVI
patients experience embolic ischemia following the procedure; however, follow-up
imaging has shown many lesions resolve (Ghanem, et al, 2010). To date, few studies

	
  
15

	
  

	
  

have used more comprehensive cognitive measures in TAVI patients than the studies
reported above.
Knipp et al. (2013) compared postoperative cognitive function after surgical
aortic valve replacement (AVR) or transapical aortic valve implantation (TA-TAVI).
Comparisons between AVR and TAVI are appropriate because TAVI is a nonstandard
procedure used instead of AVR. However, direct comparison between the groups is
inherently flawed as the TAVI patients are typically older and have a higher mortality
risk than AVR patients. Knipp and colleagues, administered different cognitive batteries
to the AVR and TAVI groups, and only a comparison of general pre to post test patterns
can be noted. TAVI participants completed the MMSE as a measure of global cognitive
function, and the researchers gave measures of verbal short-term memory, verbal
working memory, verbal learning and delayed recognition, and verbal fluency at baseline
(5.4 ± 8.1 days before the procedure), post-operative (10.7 ± 4.9 days after the
intervention), and 3-month (115.6 ± 49.7 days after the intervention) follow-up
examinations (Knipp et al., 2013). Patients in the TA-TAVI group were significantly
older and had higher estimated operative risks than the AVR group. In the TA-TAVI
group (n = 27), no significant cognitive changes were found between baseline and postoperative examinations. There was a significant increase (p < .05) in MMSE scores and
digit span backward scores in the TA-TAVI group between the post-operative and 3month follow-up evaluations. In the AVR group (n = 37), several cognitive domains (rate
of information processing, cognitive flexibility, attention, delayed recognition, verbal
working memory, visual short-term memory, and logical thinking) showed a significant
decline in performance (p <.05) between pre-operative and post-operative (10.7 ± 4.9
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days after) examinations. All domains with initial decline postoperatively returned to
baseline at 3-month follow-up with the exception of cognitive flexibility and logical
reasoning. Cognitive flexibility and logical reasoning significantly improved from
baseline to the 3-month follow-up (p < .05) (Knipp et al., 2013).
Fifty-eight percent of the TA-TAVI patients and 34% of the AVR group
evidenced new ischemic lesions on neuroimaging (Knipp et al, 2012). In both the TATAVI and the AVR groups, new ischemia was not indicative of cognitive dysfunction (p
= 0.66). These results support previous studies, in which cognitive function in the AVR
group shows decline at the postoperative evaluation, but overall regain of cognitive
function with some improvement at the 3-month follow-up. Unlike the AVR group, the
TA-TAVI group failed to show any significant decline on cognitive measures. The TATAVI group had a significant improvement in global cognitive function (MMSE) and
verbal working memory (Digit span backward) between the postoperative and follow-up
evaluations; however, the 3 month performance was not significantly different from
baseline.
Ghanem et al. (2013) had 111 TAVI patients complete cognitive testing (RBANS)
before the procedure, 3 days post, 3 months post, 1 year post, and 2 years post-TAVI.
Ghanem and colleagues (2013) also had 56 participants complete MRI protocol pre and 3
days post TAVI. Thirty participants (53.5%) evidenced new embolic events three days
following the TAVI. Participants with new embolic events did not differ from those
without embolic events in their cognitive trajectories. Despite new embolic injury,
cognitive performance remained relatively stable. Ghanem and colleagues examined
variables to predict postoperative cognitive decline (POCD), as defined as a significant
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decrease in RBANS standard score following the TAVI. Ghanem and colleagues (2013)
had only 6 participants show decline. T-tests of variables between those without POCD
(n = 105) and those with POCD (n = 6) revealed terminal renal failure requiring
hemodialysis and procedure length were significantly different between the groups.
Procedure length is used as an indirect measure of the operation complexity (Ghanem et
al., 2013).
Participants had an overall improvement in RBANS total score at the 3 days and
2-year follow-up compared to baseline (Ghanem et al., 2013). The researchers did not
discuss the transient improvement at 3 days or later improvement at the 2-year follow-up,
because the improvements were stated as not clinically significant. Significant
improvements were also found on the RBANS Immediate Memory subtest at 3 days postTAVI and on the RBANS Language subtest at 3 months. A significant decline was
observed on the RBANS Visuospatial/Constructional subtest at one year. The RBANS
subtest significant changes were transient and the scores remained or returned to baseline
at all other follow-ups (Ghanem et al., 2013). Within the 111 participants, the researchers
found a subset (n =30, 27%) that met criteria for Mild Cognitive Impairment (MCI; as
defined as >1.5 SD below expected score on their preprocedural RBANS; Ghanem et al,
2013). The cognitive trajectory of participants with MCI did not differ from those without
MCI, and participants with MCI even showed transient improvement in cognition
(Ghanem et al., 2013).
Alassar et al. (2015) compared microembolism and cognitive performance in
TAVI to surgical AVR. Eighty-five TAVI and 42 surgical AVR patients completed DWMRI at baseline, 6 days, and 3 months postprocedure. Participants also completed a
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neurocognitive assessment at baseline and at the 3-month follow-up. The neurocognitive
assessment consisted of the following measures: Memory score (complex figure test,
auditory verbal learning test), Executive functioning score (trail making test A and B,
verbal fluency test), Processing speed (symbol digit replacement, letter cancellation test,
grooved pegboard test), and Overall cognitive score (an average of the above measures).
The TAVI participants had significantly lower scores on the Memory index than AVR
participants at baseline with no other significant differences between the groups. At the 3month follow-up (TAVI n = 71, AVR n = 36), overall cognitive function significantly
improved in both the TAVI and AVR groups, and the change was significantly larger for
the AVR group than the TAVI group (Alassar et al., 2015). The AVR improved
significantly more in the memory scale than the TAVI participants (Alassar et al., 2015).
Using DW-MRI, new cerebral lesions were found in 76% of TAVI and 72% of AVR
patients at the 6-day follow-up (Alassar et al., 2015). Sixty-three percent (37 of 59) of the
TAVI patients had lesions remain visible at 3 months (Alassar et al., 2015). The authors
report that there was no association between cerebral lesions and cognitive performance.
The present study will include a more comprehensive neuropsychological
evaluation than many previous TAVI studies. Included in the evaluation are cognitive
measures that are more sensitive to cognitive changes in older adults (e.g., Repeatable
Battery for the Assessment of Neuropsychological Status) and will contain additional
measures of cognitive domains that are affected by cardiovascular disease (e.g.,
processing speed and mental control (Saxton et al., 2000)). The present study will also
assess depressive symptoms, which previous cognitive TAVI studies have not addressed.
Daily functioning measures (i.e., activities of daily living) were also included in the
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present study to examine how cognitive changes, mood, and TAVI procedure relate to the
patients' ability to function.
TAVI and Quality of Life
Activities of Daily Living
Functionality is divided into two areas: basic activities of daily living (BADL)
and instrumental activities of daily living (IADL). BADLs include every day self-care
activities such as eating, hygiene, dressing, and toileting. IADLs are tasks that allow
more independent living, such as medication management, money management,
housework, use of communication, and use of transportation. Cognitive deficit prior to
cardiac surgery (valve replacement, CABG or combined) predicts changes in IADLs
three months after the procedure (Messerotti Benvenuti, Patron, Zanatta, Polesel,
Palomba, 2014). Preoperative cognitive status was also a stronger predictor of decline in
IADLs at three months than postoperative cognitive decline (Messerotti Benvenuti et al.,
2014). Previous studies have indicated that BADL level, frailty, and physical mobility
significantly predicted all-cause mortality and major adverse cardiovascular and cerebral
events in patients following the TAVI procedure (Stortecky et al., 2012). Patients with
reduced BADL may have reduced adaptive capacities and fewer physiological reserves to
recover from the TAVI procedure.
Quality of Life
Neurological injury following cardiac surgery potentially decreases quality of life
(Newman, Grocott, Mathew et al., 2001). Quality of life (QOL) assessments often
include multiple measures of activity level, mood, perceived social support, working
status, social functioning, and health status. Level of activity measurements include
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assessment of ADLs (i.e., personal care, ambulation, and household tasks) as well as
general activity level (Newman, Grocott, Mathew et al., 2001). Although often only a
component of the QOL assessment, significant changes in ADL can likely greatly
influence a person's quality of life.
Fairbairn et al. (2012) examined health-related quality of life (HLQOL) of 102
patients undergoing the TAVI procedure. The patients completed the Social Functioning
12v2 health outcomes questionnaire and the Euro Quality of Life (EQ-5D) questionnaire
at baseline, 30 days, 6 months, and 1 year. The EQ-5D measures five dimensions of
quality of life: mobility, self-care, pain/discomfort, usual activities, and mood
(anxiety/depression). The patients demonstrated an increase in quality of life from
baseline to 30 days and to 6 months. A nonsignificant drop in HLQOL occurred from 6
months to 1 year. Predictors of increases in QOL were male gender and the surgeon's
experience with the TAVI procedure. The operator experience was an independent
predictor of QOL over complications and procedural factors (e.g., transfusion or aortic
regurgitation) (Fairburn et al., 2012).
Mood
Depressive symptoms, a component often assessed in QOL, also have important
cardiovascular and cognitive implications. Depression increases risk of cardiovascular
disease and increases mortality of patients with cardiovascular disease (Lett et al., 2004).
Depression also increases risk of stroke (Pan, Sun, Okereke, Rexrode, & Hu, 2011).
Cardiovascular disease and cerebral injury can contribute to developing late-life onset
depression (Taylor, Aizenstein, & Alexopoulos, 2013).
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Self-reported high levels of mood symptoms have also been shown to negatively

affect neuropsychological testing following cardiac surgery (Andrew, Baker, Kneebone,
& Knight, 2000). Patients undergoing cardiac surgery (n = 147) were given a
neuropsychological evaluation preoperatively (the day before the procedure) and at
discharge (mean = 6.5 days) (Andrew et al., 2000). The neuropsychological evaluation
included the California Verbal Learning Test (CVLT), Purdue pegboard, Controlled Oral
Word Association Test letter fluency, Trail Making Test (TMT) A and B, Wechsler Adult
Intelligence Scale - Revised: Digit Symbol subtest, Boston Naming Test, National Adults
Reading Test- Revised. Mood symptoms were measured using the Depression Anxiety
Stress Scales (DASS). The DASS is a 14 item self-report measure that requires the
participant to indicate both severity and frequency of anxious and depressive symptoms.
Twenty percent of the patients indicated symptoms of depression following the surgery,
of which the majority indicated depression prior to the surgery, as well. Reported anxiety
and stress on the DASS was a significant predictor of postoperative mood. Pre and
postoperative depression and anxiety significantly predicted deficits on TMT A, CVLT
total recall, and CVLT recognition discrimination (cognitive areas of attention and verbal
memory). Preoperative mood failed to predict preoperative neuropsychological tests.
Although postoperative mood symptoms were significant predictors of
neuropsychological deficit on several tests, these relationships were diminished to
nonsignificant when preoperative mood symptoms were used as a covariate (Andrew et
al, 2000). The above study demonstrates a complex relationship between mood
symptoms and neuropsychological measures in cardiac surgery patients. The addition of
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mood measures in the present study may help identify factors influencing cognition in
TAVI patients.
Frailty
Frailty will also be addressed in the present study. Frailty exhibited in the geriatric
population is defined as being "characterized by an increased vulnerability to stressors,
leading to increased risk of negative health-related events (including falls, disability,
hospitalizations, and mortality)" (Houles et al., 2012). Frailty does not have a
standardized measure, and studies often use differing criteria to establish frailty (Houles
et al, 2012). Physical frailty and cognitive impairment often co-occur (Yassuda et al.,
2012), and physical frailty with cognitive impairment is predictive of future disability
(Ávila-Funes et al., 2011). Frailty, when assessed combining independence in ADLs, gait
speed, grip strength, and serum albumin, is a significant predictor of mortality rates at
one year in TAVI patients (Green et al., 2012). Frailty status was not related to TAVI
procedural complications immediately following the procedure (Green et al., 2012). Gait
speed alone also indicates frailty. Slowed gait speed, defined as walking 5 meters in ≥6
seconds, is an independent predictor of mortality and major morbidity (e.g. stroke, renal
failure, etc) in older adults following cardiac surgery (Alfiano et al., 2010).
The Kansas City Cardiomyopathy Questionnaire (KCCQ) (Green, Porter,
Bresnahan, & Spertus, 2000) is a 23-item, self-report assessment that measures symptoms
(frequency and severity), physical function, self-efficacy and knowledge, social function,
and quality of life in patients with heart failure (Green et al., 2000). The KCCQ is valid
measure of symptoms and quality of life in patients with aortic stenosis (Arnold et al.,
2013). The KCCQ demonstrated adequate reliability and the domains of the KCCQ
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showed positive correlations with relevant reference measures (Arnold et al., 2013).
TAVI patients score significantly higher on the KCCQ overall summary score at one
month compared to baseline (p<.001, d = 0.94; Arnold et al., 2013).
Present Study
The present study will further our understanding of cognitive changes following
the TAVI procedure. TAVI is associated with an increased risk of silent ischemic injury
(Arnold et al., 2010; Ghanem et al., 2010; Kahlert et al, 2010; Rodes-Cabau et al., 2011).
Despite the risk of cerebral injury, many studies have failed to assess cognition or only
examined cognitive function through a global cognitive measure (i.e., Mini-Mental State
Examination) (Rodes-Cabau et al., 2011; Kahlert et al., 2010). Most studies using the
MMSE have failed to find cognitive changes following TAVI. In the studies using more
comprehensive cognitive assessment, cognitive abilities appear stable with some
improvements (Ghanem et al, 2013; Alassar et al., 2015). Ghanem and colleagues (2013)
found improvement on RBANS total score three days and two years after the TAVI.
Similarly, Alasssar and colleagues (2015) observed significant improvement at three
months post-TAVI in overall cognitive measures and on the memory sub-scale. The
present study will also use the RBANS, which has demonstrated sensitivity to cognitive
changes in the TAVI population (see Ghanem et al, 2013), and it will include additional
measures of processing speed, mental control, and executive function. Processing speed
and mental control are cognitive domains negatively affected by cardiovascular disease
(Saxton et al., 2000). In the present study, we predict that the participants will show a
significant improvement in processing speed, attention, executive function, and mental
control. More specifically, we anticipate results similar to Ghanem et al. (2013) with
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significant improvement on the RBANS Immediate Memory Index and the RBANS
Language Index scores.
The present study will also include non-cognitive measures (mood, functional
ability, and frailty) that have been associated with cognition and overall quality of life.
Research supports improved quality of life following the TAVI (Fairburn et al., 2012).
We predict that in addition to improvements in self-reported quality of life, we will also
find improvements in functional ability and frailty status.
Previous studies indicate that a subset of new ischemia observed on neuroimaging
within days following the TAVI procedure will resolve (Alassar et al., 2015; Knipp et al.,
2013). Therefore, the present study will examine neuroimaging at one month to more
accurately detect permanent neuronal damage. We predict that the rate of ischemic injury
will be lower than previous estimations (e.g., 84% in Kahlert et al., 2010) due to the onemonth delay. The cognitive sequelae of ischemia following cardiac procedures are
debated (see above). Recent studies using MRI in TAVI patients fail to support that
ischemic changes have a significant effect on cognition (Ghanem et al, 2013; Alassar et
al., 2015). Therefore, new lesions are predicted to have no relationship with postoperative
cognitive functioning. Instead, medical variables, such as procedure length and chronic
kidney disease have been associated with post-operative cognitive decline (Ghanem et
al., 2013). We predict that the measures of overall medical health (i.e., the Society for
Thoracic Surgeons score) and procedural variables (i.e., procedure length) will predict
post-operative cognitive performance.
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CHAPTER II
METHOD
Participants
The interventional cardiologist at The Sanford Medical Center in Fargo, North
Dakota identified patients eligible for the TAVI procedure, and a clinical research
coordinator obtained informed consent. Participants completed a baseline cognitive
assessment and DW-MRI one day prior to the TAVI procedure and at a one-month
follow-up (30.67 day ± 5.46). Participants with diminished capacity to consent were
excluded from the study. Patients non-fluent in English were excluded. As the TAVI
procedure is an alternative procedure for high mortality risk patients, patients with healthrelated issues that may affect cognition were not excluded. Specifically, uncontrolled
hypertension, coronary artery disease, carotid disease, chronic obstructive pulmonary
disease, parkinsonism, history of stroke, history of cancer, history of prior CABG are
common in the TAVI population and may affect cognition. However, patients with the
above conditions were not excluded, as they are believed to be representative of the
population. Patients needing combined heart surgery (i.e., multiple valve disease, patent
foramen ovale, etc.) or multiple vascular surgeries (i.e., ascending aortic aneurysm and
carotid revascularization) were excluded. To reduce attrition, noncompliant patients, as
defined as an inability to complete the Mini-Mental State examination and the RBANS
were excluded. Patients were excluded from the neuroimaging portion of the study when
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an MRI was contraindicated (e.g., claustrophobia, internal ferromagnetic material as a
result of trauma, surgery, or implant), but the cognitive evaluation was still completed.
Fifty participants were recruited from Sanford Medical Center in Fargo, North
Dakota. Forty participants were seen at one month. Three participants died before the
follow-up. Deaths resulted from TAVI complications including embolic event to the
bowels (death 2 days post-TAVI), aortic dissection (death 5 days post-TAVI), and during
the TAVI procedure (surgical complications). Three participants chose to withdraw at the
follow-up: one participant was hospitalized during the follow-up and cited poor health as
the reason for withdrawal; one participant failed to attend the follow-up appointment and
withdrew when contacted to reschedule. One participant did not tolerate cognitive testing
at the follow-up and failed to complete the MMSE and RBANS. Two participants
completed the baseline evaluation, but the TAVI procedure was canceled or delayed due
to medical conditions or patient decision (i.e., urinary tract infection, decided to forgo the
intervention). A scheduling error resulted in one participant failing to complete the
follow-up.
Cognitive Evaluation
Participants completed cognitive testing within 24 hours prior to the procedure
and 30.67 ± 5.46 days later. The follow-up cognitive assessment was scheduled to
coordinate with the TAVI postoperative medical follow-up. The following tests were
administered during the first testing session: Mini-Mental State Exam (Folstein, Folstein,
& McHugh, 1975), Wechsler Test of Adult Reading (Holdnack, 2001), Repeatable
Battery for the Assessment of Neuropsychological Status (RBANS; Randolph, 1998),
Stroop Color-Word Interference Test (Golden, 1978), Trail Making Test A and B (Reitan
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& Wolfson, 1993), Letter Fluency (Benton & Hashmer, 1983), Verbal Series Attention
Test (Mahurin & Cooke, 1996), Wechsler Adult Intelligence Scale–Fourth Edition
(WAIS-IV) Digit Span subtest (Wechsler, 2008), and the Geriatric Depression Scale
(Yesavage, Brink, Rose, Lum, & Huang, 1983). The follow-up examination was identical
except the Wechsler Test of Adult Reading was not administered. The RBANS has two
alternate forms: RBANS-A and RBANS-B. Administration was counterbalanced such
that half of the participants completed RBANS-A initially and RBANS-B at the followup, and the other half completed RBANS-B during the pre-procedure assessment and
RBANS-A during the follow-up. A family member or caregiver completed the informant
questionnaires (Functional Activities Questionnaire (Pfeffer, Kurosaki, Harrah, Chance,
& Filos, 1982), Physical Self Maintenance Scale (Lawton & Brody, 1969), and the
Dementia Severity Rating Scale (Clark & Ewbank, 1996)) during the pre- and post-TAVI
evaluations.
Cognitive Assessment Materials
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
The RBANS is a brief cognitive battery developed to screen for cognitive decline
in older adults. The RBANS contains 12 subtests and takes approximately 25 minutes to
administer. Subtests are combined to yield 5 indices: Immediate Memory,
Visuospatial/Constructional, Language, Attention, and Delayed Memory. Indices can be
combined to calculate a Total Scale Score. the RBANS test-retest reliability was
calculated for retest intervals between 1 and 134 days, and the length of the interval did
not significantly affect the test-retest reliability. The RBANS subtest test-retest reliability
coefficients range from 0.52 (List Learning) to 0.83 (Coding), and the indices test-retest
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reliability coefficients range from 0.68 (Visuospatial/Constructional) to 0.80 (Delayed
Memory; Randolf, 2012). In construct validity studies, the RBANS subtests correlated
with measures of similar cognitive abilities; for example RBANS
Visuospatial/Constructional Index correlated highly with the Rey-Osterrieth Complex
Figure Copy, and the RBANS Attention Index correlated highly with the Wechsler
Memory Scales - Revised Attention/Concentration Index (Randolf, 2012). The RBANS
subtests are described below.
1) List Learning and Story Memory subtests comprise the Immediate Memory
Index. During List Learning, individuals learn a verbally presented 10-word list over four
trials. Scores are recorded for recall after each trial and for total recall over all four trials.
In Story Memory, individuals learn a story containing 12 parts or ideas over two verbally
presented trials. Scores are calculated by combining story part recall for each trial.
2) Visuospatial/Constructional index contains the subtests Figure Copy and Line
Orientation. The Figure Copy requires the participants to copy a 10-part geometrically
complex figure. A four-minute time limit is given for Figure Copy, which far exceeds the
time necessary for most people to complete the task. Time required to complete the
drawing is recorded, but does not influence the Figure Copy score. The participants are
instructed that they are timed during the Figure Copy, but that their score is based on the
accuracy of the drawing. The Line Orientation subtest requires individuals to correctly
identify the matching orientation of two target lines to a 13-line array spanning 180
degrees.
3) The Language index consists of Picture Name and Semantic Fluency subtests.
Picture Naming requires the individual to name line drawings of objects. If the individual
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misperceives the picture, a semantic cue is given. In Semantic Fluency, participants are
presented with a category (e.g., Fruits and Vegetable) and have 60 seconds to generate
words within the category.
4) Digit Span and Coding comprise the Attention Index. The Digit Span subtest
requires the participant to repeat verbatim strings of digits verbally presented by the
examiner. During the Coding subtest, participants quickly match numbers to a series of
symbols using a key. Coding is a timed test.
5) List Recall, List Recognition, Story, Recall, and Figure Recall comprise the
Delayed Memory Index. List Recall is a free recall measure from the word list presented
in List Learning. The List Recognition subtest requires the participant to identify the
word list words amongst distracters by providing "yes" or "no" responses. The Story
Recall subtest is a free recall task for the story presented in Story Memory. The Figure
Recall subtest requires the participant to draw the geometric figure from Figure Copy
from memory with no time limit. All delayed recall subtests occur approximately 10-15
minutes after the original stimulus presentation.
The figure copy and recall were scored with awareness to pre and post-TAVI
status. Ten percent of the figures were re-scored by a research assistant blinded to the
pre- and post-TAVI status. The calculated inter-rater reliability percent agreement was
0.93, indicating adequate scoring agreement.
Mini-Mental State Examination
The Mini-Mental State Examination (MMSE) is a global cognitive screening
measure (Folstein, Folstein, & McHugh, 1975). The MMSE consists of brief
measurements of multiple cognitive domains, including orientation to time and place,
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memory encoding and recall, complex attention, language production and reception, and
visuospatial/constructional abilities. The MMSE has adequate reliability and
demonstrates good validity, as evidenced by high correlations with criteria measures of
cognitive impairment (i.e., the Diagnostic and Statistical Manual for Mental Disorders
and the National Institute of Neurological and Communicative Disorders and StrokeAlzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) Alzheimer's
criteria; Tombaugh & McIntyre, 1992). The MMSE is often used as a dementia screening
in older adults with scores < 24 representing probable cognitive impairment (Folstein,
Folstein, & McHugh, 1975).
Stroop Color-Word Interference Test
The Stroop Color-Word Interference Test (Golden, 1978) consists of three
sections, each with a 45 second time limit. In the first section, the participant is required
to read a list of color words (e.g., red, blue, etc.) at a rapid rate. In the second section, the
participant is presented a list of X's printed in different colors. The second section
requires the participant to provide the color of ink the series of X's is printed in (e.g.,
"XXXXX" printed in red ink and the participant would respond "red") at a rapid rate. For
the third section, the participant is presented with color words printed in incongruent ink
colors (e.g., the word "red" written in blue ink). The participant is required to rapidly
provide the ink color while ignoring the word. The first two sections of the Stroop
provide processing speed measures. The third section measures inhibition, an executive
function requiring attention and inhibition of prepotent responses (i.e., reading the written
word). The test-retest reliability for the three trials are 0.89, 0.84, and 0.73, respectively
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(Golden, 1975). The third trial (Word-Color interference) correlates with established
measures of prepotent response inhibition and attention (May and Hasher, 1998).
Test of Premorbid Functioning
The Test of Premorbid Functioning (Wechsler Test of Adult Reading: WTAR)
requires the participant to read aloud a list of words (Holdnack, 2001). The WTAR words
have atypical pronunciations based on common English rules (e.g., ogre). The WTAR is
used to estimate overall cognitive ability prior to a cerebral injury, such as traumatic
brain injury or degenerative disease. The WTAR demonstrates adequate reliability and
correlates well with verbal intelligence quotients (Whitney, Shepard, Mariner,
Mossbarger, Herman, 2010).
Trail Making Test A and B
The Trail Making Test (TMT) consists of two subtests (Reitan & Wolfson, 1993).
In the first subtest (Trail A), participants are presented a page with circles each
containing a number (unordered). The participant is required to connect the numbers in
ascending numerical order at a fast rate without error. In the second subtest (Trail B),
participants are presented a page with circles each containing a number or a letter. The
participant is required to connect the circles in alternating order (1 to A, A to 2, 2 to B, B
to 3, etc.) at a rapid rate without error (Reitan & Wolfson, 1993). The test-retest
reliability for TMT Part A is 0.79 and 0.89 for Part B (Dikmen, Heaton, Grant, &
Temkin, 1999). TMT Part A measures primarily visual search and processing speed;
TMT Part B measures both working memory and task-switching performance (SanchezCubillo et al., 2009)
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Letter Fluency
In letter fluency, participants are given a letter and asked to generate words that
begin with that letter (Benton & Hashmer, 1983). Letter fluency consists of three 60second trials with a different letter in each trial. Letter fluency is a well-established
neuropsychological assessment measure of executive function, verbal ability, and
processing speed (Strauss, Sherman & Spreen, 2006, pp. 499- 526).
Verbal Series Attention Test
The Verbal Series Attention Test (VSAT; Mahurin & Cooke, 1996) requires the
participant to say series of letters, words, or numbers. Participants are informed that
speed and accuracy are important. The VSAT requires verbal recall and/or mental
manipulation of overlearned material (e.g., "say the alphabet"; "say the days of the week
backward", etc.). The VSAT generates scores for overall time to complete the items and
number of errors. The VSAT is a measure of mental control and attention. The VSAT
Time score has good test-retest reliability (r = 0.86), and adequate construct validity as a
measure of attention (i.e., highly correlates with the WAIS-R Freedom From
Distractibility factor; Mahurin & Cooke, 1996).
WAIS-IV Digit Span Subtest
For the present study, only the backward subsection of the Digit Span subtest was
completed. During Digit Span Backward, the examiner reads a series of numbers and the
participant is required to repeat the series in reverse order. The number strings increase in
length until the participant can no longer complete the task correctly. Digit Span
Backward measures complex attention. The Digit Span backward test is a measure of
working memory (Wechsler, 2008).
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Geriatric Depression Scale
The Geriatric Depression Scale (GDS) is a 30-item yes/no response, self-report
questionnaire developed to measure depressive symptoms in older adults (Yesavage et
al., 1983). The test items focus on the psychological symptoms associated with
depression and excludes physiological symptoms that are more likely confounded by age
and disease. The GDS demonstrates adequate internal consistency and correlates highly
with other measures of depression in an elderly sample (Yesavage et al., 1983).
Informant Questionnaires
The informant questionnaires assess the participant's level of functioning through
a caretaker's report. The Physical Self-Maintenance Questionnaire (PSMS; Lawton &
Brody, 1969) is a multiple-choice questionnaire that assesses level of independence in the
following basic activities of daily living (BADLs): toilet use, feeding, dressing,
grooming, physical ambulation, and bathing. The PSMS has test-retest reliability of 0.94
and has high correlations with physicians' ratings and other measures of activities of daily
living (Lawton & Brody, 1969). The Functional Activities Questionnaire (FAQ; Pfeffer,
Kurosaki, Harrah, Chance, & Filos, 1982) measures instrumental activities of daily living
(IADLs) such as managing personal finances and meal preparation. The FAQ has high
inter-rater reliability and adequately discriminates normal controls from patients with
dementia (Pfeffer et al., 1982). Typically, IADLs represent activities that require higher
cognitive function than BADLs. The Dementia Severity Rating Scale (DSRS; Clark &
Ewbank, 1996) is a multiple-choice questionnaire measuring major cognitive and
functional typically impaired in individuals with dementia. The DSRS has good test-
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retest reliability and correlates highly with cognitive measures and with other validated
measures of dementia severity (Clark & Ewbank, 1996).
Frailty Measures
The frailty assessment included the gait speed, the KCCQ, and fatigue/exhaustion.
The Kansas City Cardiomyopathy Questionnaire (KCCQ; Green, Porter, Bresnahan, &
Spertus, 2000) was used to measure activity level and quality of life. The KCCQ is
included in the standard pre and post TAVI evaluations by the heart team. The KCCQ is
a 23-item, self-report assessment that measures symptoms (frequency and severity),
physical function, self-efficacy and knowledge, social function, and quality of life in
patients with heart failure (Green et al., 2000). Two questions from the Center for
Epidemiologic Studies Depression Scale (CES-D; Radloff, 1977) ("I felt that everything I
did was an effort" and "I could not get going") were included at the end of the GDS as a
measure of frailty. The two CES-D questions as exhaustion measures have been used in
previous research of frailty and surgical outcomes (Makary et al., 2010). Patients rating
either question with a 2 (occurred 3-4 days in the past week) or 3 (occurred 5-7 days in
the past week) on either question meet criteria for exhaustion. As a measure of gait speed,
patients were asked walk 5 meters at walking speed. Participants with ≥6 seconds on the
5 meter walking test met criteria for frailty (Alfiano, Eisenberg, Morin, et al., 2010).
Participants responding with a "2" or "3" on either CES-D question and with a gait speed
greater than 6 seconds qualified as frail in the present study.
Magnetic Resonance Imaging
MRI data was acquired within 24 hours pre-TAVI and at the 1-month follow-up.
A 1.5T magnet utilizing a standard head was used for imaging. Images were assessed for
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small vessel ischemic change, old infarcts, microhemorrhages, and acute ischemia by a
neuroradiologist at Sanford Health. Medically relevant findings from the MRIs, as
determined by the radiologist and interventional cardiologist, were shared with the patient
as necessary. Data collected from the MRI images will include number new ischemic
lesions.
Medical Variables
Variables with prior research to support their use in the present study were
extracted from the participants' medical records. Medical variables of interest are listed in
completion in Table 1. For purposes of the present study, presence of coronary artery
disease, uncontrolled hypertension, history of neurological disease, history of prior
coronary artery bypass grafting, chronic kidney disease and chronic obstructive
pulmonary disease were extracted from electronic medical records for general
demographics of the TAVI patient population health status. As TAVI procedure length
potentially influences post-TAVI cognitive outcomes (Ghanem et al., 2013), it was also
included in further analyses.
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CHAPTER III
RESULTS
Data Screening
All variables were examined for outliers and normality. Using an a priori
criterion of beyond two standard deviations, no outliers were eliminated from any
variables. Normality was assessed using the Shapiro-Wilk test of normality and Fisher's
coefficient for skewness and kurtosis measures. Shapiro-Wilk values with p < 0.05
indicate the variable is not normally distributed. Fisher's coefficient is calculated using
skewness divided by the standard error of skewness, and calculated values outside of
±1.96 indicate the distribution is significantly skewed (Howell, 2010, Chapter 2). The
following variables were not normally distributed: RBANS (Line Orientation, Picture
Naming, List Recall, List Recognition, Figure Recall), Digit Span Backward, Verbal
Series Attention Test, Trail Making A Time, Trail Making B Time, and all informant
rating scales.
Variables that failed normal distribution measures were transformed to improve
their normality. The type of data transformation was determined by the skewness
direction (i.e., positive or negative) and the severity of the skewness (i.e., moderate,
substantial, or severe). For positively skewed distributions, data were transformed using
formulas in Mertler and Vannatta (2010, p. 32) by attempting transformations for
moderate skewness (square root) then substantial skewness (logarithm) then severe
skewness (inverse) until normality was achieved. For distributions negatively skewed,
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data were reflected (i.e., (K - X), in which the constant (K) creates the smallest value of
one) before their subsequent transformation (Mertler & Vanatta, 2010, p. 31). Reflection
causes the distribution to become positively skewed, and the subsequent transformation
(i.e., square root, logarithmic, or inverse) to correct the positive skewness to a more
normal distribution (Mertler & Vanatta, 2010, p. 31) The RBANS List Recall Raw
distribution was positively skewed (post-TAVI Fisher coefficient = 2.70), and data were
transformed using the inverse to achieve normality. The RBANS Figure Recall pre-TAVI
had a significant Shapiro-Wilk value (p = 0.014). Pre and Post RBANS Figure Recall
data were transformed using reflection and square root transformation. The pre and postTAVI Digit Span Backwards distributions were positively skewed, and the post-TAVI
Digit Span Backward Shapiro-Wilk was significant (p = 0.009). A logarithmic
transformation on Digit Span Backward raw score improved normality (Shapiro-Wilk
value = 0.95, p = 0.11). The pre and post-TAVI Verbal Series Attention Test (VSAT)
time also positively skewed. A logarithmic transformation on the VSAT Time improved
normality (Shapiro-Wilk p > 0.05). The Trailmaking Test (TMT) A and B time for both
pre- and post-TAVI were positively skewed. An inverse transformation for the TMT A
Time was performed to improve normality (pre-TAVI TMT A Shapiro-Wilk p = 0.067,
post-TAVI TMT A Shapiro-Wilk p = 0.58). A logarithmic transformation on TMT B
time raw score improved normality (pre-TAVI Shapiro-Wilk value p = 0.49, post-TAVI
Shapiro-Wilk value p = 0.79). The following variables did not achieve normality after
transformations: RBANS Figure Copy, RBANS Line Orientation, RBANS Picture
Naming, RBANS List Recognition, TMT A errors, TMT B errors, FAQ, DSRS, PSMS.
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Patient Characteristics
Patient characteristics are summarized in Table 2.

Table 2
Sample Baseline Characteristics
Variable
n

Mean±SD

Range

Age

46

79.04±7.79

59-90

Education Level

43

12.51±3.75

6-20

WTAR Standard Score

40

97.23±12.59

81-123

Male

29

--

--

Female

17

--

--

BMI

46

31.15±6.54

21-47

STS Score

45

6.65±3.09

1.47-15.50

EuroScore

19

9.07±5.54

1.06-20.36

18 (39%)

--

--

Type I

2

--

--

Type II

16

--

--

NYHA Class

32

--

--

I

4

--

--

II

8

--

--

III

19

--

--

IV

1

--

--

CKD

16 (35%)

--

--

Hyperlipidemia

33 (72%)

--

--

Hypertension

34 (74%)

--

--

COPD

7 (15%)

--

--

Gender

Diabetes
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Table 2. cont.
Variable

n

Mean±SD

Range

11 (24%)

--

--

Depression

6 (13%)

--

--

Anxiety

2 (4%)

--

--

Mood Disorder

Mixed Anxiety/
Depression or
unspecified
Carotid Disease

3 (7%)

--

--

9 (20%)

--

--

CAD

33 (72%)

--

--

14 (31%)

--

--

Prior CABG

BMI = body mass index; STS = The Society for Thoracic Surgeon's risk score; NYHA
= New York Heart Association Functional Classification; CKD = chronic kidney
disease; COPD = chronic obstructive pulmonary disease; CAD = coronary artery
disease

Procedural Characteristics
TAVI procedural characteristic data were collected for 46 participants. Table 3
summarizes these data.
Table 3
TAVI Procedural Data
Variable

n

Mean±SD

Valve Type

46

--

Edward SAPIEN

34

--

CoreValve

12

--

--

--

23 mm

14

--

26 mm

17

--

29 mm

8

--

31 mm

7

--

Valve Size
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Table 3. cont.
Variable

n

Mean±SD

Procedure Route
Transfemoral

36

Transapical

9

Valve in Valve

2

--

Pre- Mean Gradient

44

46.84±8.28

Post- Mean Gradient

39

11.31±5.10

149.9

98±212

43

4.05±4.91

Procedure Length
(minutes)
Length of Stay

Edward SAPIEN = transcatheter heart valve, Edwards Lifesciences
device; CoreValve = Medtronic transcatheter aortic valve replacement
system

Cognitive Assessment
Dependent t-tests were used to compare pre and post-TAVI cognitive measures.
Variables not normally distributed were excluded from the analyses.
The results for the RBANS t-tests are presented in Table 4. Results of the
dependent t-test using the RBANS show that the Language Index significantly differs
from baseline (M = 91.42, SD = 9.04) to one month post-TAVI (M = 95.50, SD = 10.86, t
= -2.59, df = 37, p = 0.014, d = 0.42). The participants scored, on average, 4.08 points
higher at one month than prior to the TAVI procedure.
At the RBANS subtest level, results of the dependent t-test show that the Fluency
subtest improved significantly from baseline to one month post-TAVI (p = 0.023, d =
0.38). Results also show significant decline on the List Recall subtest from baseline (M =
3.21, SD = 2.22) to one-month post-TAVI (p = 0.001, d = 0.56). On average, participants
recalled about one less word (mean difference = 0.90) at one month than baseline. Results
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Table 4.
RBANS Dependent t-tests comparing baseline and one month post-TAVI
Pretest
Posttest
Variable
M
SD
M
SD
t

df

RBANS Total
Index

85.26d

14.69

85.74d

13.41

-0.33

34

Immediate
Memory Index

84.33d

15.76

84.46d

15.85

-0.055

38

List Learning 19.80

5.49

19.43

5.32

0.43

39

Story Learning 12.97

4.39

13.33

4.80

-0.56

38

18.90

89.66d

17.77

0.96

37

Figure Copyc 16.36

2.67

16.41

3.13

--

--

Line Orientationc 14.76

4.58

14.03

4.89

--

--

9.04

95.50d

10.86

-2.59*

37

0.84

9.46

0.72

--

--

3.57

16.10

4.35

-2.36*

38

15.74

86.89d

14.50

0.18

35

2.07

8.67

2.11

0.79

38

9.42

29.89

9.53

-0.37

35

16.42

87.55d

15.81

-0.87

37

2.22

2.31

2.23

-3.44*

37

1.95

17.45

2.18

--

--

Story Recall 6.44

2.81

6.64

2.93

-0.48

38

Figure Recallb 9.51

5.62

10.85

5.31

2.31*

37

Visuospatial/
Constructional
Index

Language Index

92.11d

91.42d

Picture Namingc 9.36
Fluency 14.59
Attention Index

87.25d

Digit Span 8.92
Coding 29.58
Delayed Index

85.63d

List Recalla 3.21
List Recognitionc 17.55
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Table 4. cont.
M = mean, SD = standard deviation, df = degrees of freedom,
a
t-test completed with inverse transformation data to achieve normality
b
t-test completed with reflected a square root transformation to achieve normality
c
t-test not completed due to failure to meet assumptions
d
standard scores derived from raw score transformations using RBANS Manual
* p < 0.05

show significant improvement on the Figure Recall subtest from baseline to one month
post-TAVI (p = 0.027, d = 0.37). No other significant differences were observed between
baseline and at one month on RBANS measures.
Dependent t-tests comparing baseline to one month post-TAVI were completed
for the following cognitive measures: Trailmaking Test A and B, Verbal Series Attention
Test, WAIS-IV Digit Span Backward, Letter Fluency, Stroop Color-Word Interference
Test, Mini-Mental State Examination. Results are presented in Table 5. No significant
differences were observed.
Table 5.
Dependent t-tests comparing baseline and one month post-TAVI on cognitive measures
Pretest
Posttest
Variable
M
SD
M
SD
t
df
MMSE

25.88

2.81

25.75

3.17

0.321

39

VSAT Timea

130.50

41.22

130.20

46.33

0.23

34

Trail Making Test

--

--

--

--

--

--

25.45

56.38

32.88

-1.62

33

0.22

0.18

0.46

--

--

61.48

151.96

80.86

-1.31

24

0.80

0.93

1.04

--

--

A: Time (sec)a 51.44
A: Errorb 0.05
B: Time (sec)a 139.28
B: Errorb 0.53
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Table 5. cont.
Pretest
M

SD

Posttest
M

SD

t

df

Digit Span
Backwarda

7.26

1.83

8.67

2.11

0.27

34

Stroop

--

--

--

--

--

--

Word 72.72

15.27

73.52

15.41

-0.41

32

Color 49.31

10.54

49.28

12.57

0.02

31

7.06

24.53

8.53

-1.94

31

11.83

27.43

11.01

-0.73

34

Variable

Word-Color 22.25
Letter Fluency
a
b

25.51

t-test completed with logarithmic transformation data to achieve normality
t-test not completed due to failure to meet assumptions
A standard multiple regression was conducted to determine if the independent

variables procedure length, difference in mean gradient, and STS score predict the change
in RBANS Total Index Score. Procedure length is an indirect measure of the operation
complexity. The mean gradient is a measure of valve efficiency, and is routinely used to
measure the severity of aortic stenosis. The STS score represents an estimated mortality
percentage that is obtained using an algorithm that combines multiple chronic medical
conditions and previous cardiovascular risk factors. Regression results indicate that the
overall model does not significantly predict the change in RBANS Total Index scores
(R2adj = 0.008, F(3,27) = 0.946, p = 0.375). The model accounts for 10.6% of the variance
in the change in RBANS Total Index score in the sample. The regression coefficients are
presented in Table 6.
The regression was repeated with the same independent variables to predict
change in scores that showed significant change on previous t-tests: RBANS Language
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Table 6.
Regression coefficients for model predicting change in RBANS Total Index score
ß
t
p
Partial r
Procedure Length
-0.167
1.754
0.091
-0.160
(minutes)
STS score

0.523

-0.316

0.754

-0.61

Change in mean
gradient

0.211

-0.842

0.407

0.320

STS = The Society for Thoracic Surgeon's risk score

Index, RBANS Fluency, List Recall, and Figure Recall. In predicting RBANS Language
Index change, regression results indicate that the overall model does not significantly
predict the change in RBANS Language Index scores (R2adj = -0.050, F(3,28) = 0.504, p
= 0.682). The model accounts for 5.1% of the variance in the change in RBANS
Langauge Index score in the sample. In predicting RBANS Fluency change, regression
results indicate that the overall model does not significantly predict the change in
RBANS Fluency scores (R2adj = -0.076, F(3,29) = 0.244, p = 0.865). The model accounts
for 2.46% of the variance in the change in RBANS Fluency subtest score in the sample.
In predicting RBANS List Recall subtest raw score change, regression results indicate
that the overall model does not significantly predict the difference (R2adj = 0.126, F(3,28)
= 2.468, p = 0.081). The model accounts for 2.1% of the variance in the change in
RBANS List Recall subtest score in the sample. In predicting RBANS Figure Recall
subtest raw score change, regression results indicate that the overall model does not
significantly predict change (R2adj = -0.016, F(3,28) = 0.836, p = 0.485). The model
accounts for 8.2% of the variance in the change in RBANS Figure recall subtest score in
the sample.
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Mood, Quality of Life, and Frailty Assessment
Dependent t-tests were used to compare pre and post-TAVI quality of life

measures. Variables not normally distributed were excluded from the t-test analyses.
Results are summarized in Table 7.
Results of the GDS dependent t-test revealed a significant decrease from baseline
to one month post-TAVI (p = 0.018, d = 0.41). The participants endorsed on average 1.50
less depressive symptoms at one month than prior to the TAVI procedure. Results also
show significant increase on the KCCQ from baseline to one-month post-TAVI (p <
0.001, d = 1.08).
Table 7.
Dependent t-tests comparing baseline and one month post-TAVI on quality of life
measures
Pretest
Posttest
Variable
M
SD
M
SD
t
df
KCCQ

38.93

9.81

51.55

9.99

-6.80**

39

GDS

7.33

4.78

5.83

4.09

2.47*

35

Gait Speed

5.77

1.59

5.32

1.56

1.56

34

FAQ

7.00

10.27

6.69

10.10

--

--

DSRS

3.81

4.67

3.48

5.75

--

--

PSMS

7.26

1.90

7.42

2.06

--

--

KCCQ = Kansas City Cardiomyopathy Questionnaire; GDS = Geriatric Depression Scale; FAQ =
Functional Activities Questionnaire; DSRS = Dementia Severity Rating Scale; PSMS = Physical Self
Maintenance Scale
* p < 0.05
** p < 0.001

Participants were defined as "frail" when gait speed for 5 meter walk exceeded 6 seconds
and at least one CES-D question was endorsed (see "Frailty" in literature review for
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detailed description). Seven participants (7 of 37, 19%) met frailty criteria at baseline.
Two participants (2 of 34, 6%) met frailty criteria at one month. Five participants that
were frail at baseline were no longer frail at one month, and two participants maintained
frailty status at one month. A summary of the frailty characteristics is presented in Table
8. No statistical analyses were conducted on the frailty data.
Table 8
Summary of group data for participants meeting frailty criteria
n
MMSE
RBANS
GDS
Frail at baseline

7

27.4

73.9

10.7

Frail at one month

2

24.5

78

9

RBANS = Repeatable Battery for the Assessment of Neuropsychological Status
Total Index Score mean; Frail = gait speed >6 seconds/5meters and
endorsement on at least one CES-D question for frailty; MMSE = Mini-Mental
State Examination mean; GDS = Geriatric Depression Scale

Neuroimaging and Cognitive Performance
Thirty-five baseline and 22 one-month follow-up MRI protocols were completed.
Six participants (27.2%) evidenced new ischemic lesions at one month. Characteristics
and cognitive performances for participants with evidence of new ischemia are presented
in Table 9.
A series of Mann-Whitney U tests were computed to compare cognitive
performance in participants with new lesions (n = 6) to those without (n = 16).
Participants with new ischemia were not significantly different than those without
ischemia on post-TAVI RBANS Total Index (U = 37, z = -0.81, p = 0.45). Participants
with new ischemia did not significantly differ from participants without new ischemia on
RBANS Index scores (Immediate Memory Index, U = 40, z = -0.59, p = 0.59;
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Table 9
Characteristics of participants with new ischemia evidenced on MRI at one month
Baseline
Follow-up
Participant

RBANS

MMSE

RBANS

MMSE

Change

1

110

27

103

29

-7

2

82

23

82

23

0

3

91

28

68

28

-23*

4

70

26

76

22

+6

5

70

23

73

26

+3

6

97

30

101

28

+4

RBANS = Repeatable Battery for the Assessment of Neuropsychological Status Total Index Score;
MMSE = Mini Mental State Examination; Change = Post RBANS Total Index - Pre RBANS Total
Index
*significant change based on reliable change index (1.96*Standard Error of Measurement)

Visuospatial/Constructional Index, U = 45.5, z = -0.19, p = 0.86; Language Index, U =
44, z = -0.30, p = 0.80; Attention Index, U = 50, z = 0.15, p = 0.91; Delayed Memory
Index, U = 34.5, z = -1.00, p = 0.33).
Wilcoxon Signed Rank tests were used to compare pre and post-TAVI
performance in participants with new ischemic lesions. The Wilcoxon Signed Rank tests
results are summarized in Table 10. The Wilcoxon Signed Rank tests demonstrated no
significant differences between pre and post-TAVI cognitive measures. The Wilcoxon
Signed Rank test revealed a significant difference between and pre and post-TAVI mean
gradient scores.
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Table 10
Wilcoxon Signed Rank Tests results in participants (n = 6) with new
ischemic lesions
Variable
z-score

p

MMSE

0.00

1.00

RBANS Total Score

-0.41

0.69

RBANS Immediate Memory Index

-0.14

0.89

RBANS Visuospatial/Constructional Index

-1.47

0.14

RBANS Language Index

-0.42

0.67

RBANS Attention Index

0.00

1.00

RBANS Delayed Memory Index

-0.67

0.50

RBANS Fluency Subtest

-0.63

0.53

RBANS List Recall Subtest

-0.54

0.59

RBANS Figure Recall

-0.42

0.67

DSB

0.00

1.00

Stroop Word-Color Test

-0.27

0.79

KCCQ

-1.75

0.08

GDS

-0.41

0.68

Mean Gradient

-2.02

0.043*

Stroop Word-Color = third trial of the Stroop Word-Color Test; KCCQ = Kansas City
Cardiomyopathy Questionnaire
* = p < 0.05
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CHAPTER IV
DISCUSSION
The TAVI patient population is older adults (M = 79.04 years old, SD = 7.79) with
multiple medical conditions (see Table 2). The patient population has high rates for
chronic medical conditions (i.e., chronic kidney disease, chronic obstructive pulmonary
disease, coronary artery disease, etc.) that potentially contribute to changes in functional
abilities and cognitive functioning. Therefore, the TAVI population has unique cognitive
concerns. The present study's sample had an education level slightly above high school
(M = 12.51, SD = 3.75, range 6 to 20) and an estimated premorbid cognitive ability in the
average range (WTAR Standard Score, M = 97.23, SD = 12.59). Despite estimated
average cognitive functioning, when compared to similar aged adults at baseline, some
areas of cognitive functioning fell into low average range (Standard Score (SS) = 80-89):
RBANS Total Index, Immediate Memory Index, Attention Index, Delayed Index
Standard Scores. On the RBANS, language and visuospatial/constructional abilities were
within the average range (SS = 90-109). Mild decline in attention and verbal memory are
consistent with the cognitive sequalae of cardiovascular diseases, and consistent with
previous research of pre-cardiac surgery patients (Silbert, Scott, Evered, Lewis, Maruff,
2007).
In TAVI patients, the overall cognitive functioning appears stable one month
following the procedure. Of the 23 cognitive measures compared (pre versus post-TAVI)
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only 4 showed significant change (three measures improved and one declined). The
observed significant changes are likely not clinically significant (see below), and without
a control group comparison we cannot conclude that these changes exist beyond those
expected through practice effects. There were statistically significant improvements in
the RBANS Language Index, the RBANS Fluency subtest, and the RBANS Figure Recall
subtest. The mild improvements are consistent with previous studies; Ghanem and
colleages (2013) also found a significant improvement on the RBANS Language Index at
a 3-month post-TAVI evaluation. At the subtest level, a significant improvement was
observed on the Fluency subtest of the Language Index. The Picture Naming subtest was
not analyzed because it failed normality assumptions. Ghanem et al. (2013) did not
analyze results at the subtest level, so it is unknown if an increase in Fluency was also
consistent with their results. Letter fluency was also examined in the present study, which
requires participants to give words beginning with a certain letter rather than words
within a semantic category (as in the RBANS). When participants were given the
phonemic cues (Letter Fluency) no significant improvement was observed. There are
several reasons why RBANS Fluency and Letter Fluency produced different results.
First, RBANS Fluency is based on one trial while Letter Fluency scores are comprised of
three trials. Second, the RBANS Fluency was introduced before Letter Fluency, so task
familiarity and practice effects may have influenced Letter Fluency performance. Third,
semantic and phonemic fluency tasks likely engage different brain areas, with phonemic
fluency being more sensitive to frontal lobe dysfunction (Strauss, Sherman, & Spreen,
2006). Although Fluency loads the Language Index on the RBANS, semantic fluency is
often considered an executive or frontal lobe function (Butler, Rorsman, Hill & Tuma,
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1993). Other measures of executive function did not significantly change (Trailmaking B,
VSAT, Digit Span Backward). However, Stroop Word-Color Interference (i.e., trial
three) was near significance (p = 0.06). The improvement on RBANS Fluency exists
without generalized executive function improvement.
The significant improvement of RBANS Figure Recall and significant decline on
RBANS Delayed List Recall may have nullified any changes in overall memory
performance. The present study's results are consistent with Ghanem and colleagues
(2013) who also did not find a significant change in delayed memory. However, Alassar
and colleagues (2015) did find an improvement in memory performance using a complex
figure test and auditory verbal learning test. The complex figure and auditory verbal
learning test may be more sensitive to changes in delayed memory than the RBANS. The
improvement in visual memory (Figure Recall) and decline in verbal memory (List
Recall) could be unique to our sample or could be representative of trends in the
population. Future research examining memory performance in the TAVI population may
benefit from differentiating language and visual memory tasks.
The present study failed to find significant change in mental control and
processing speed, as predicted. Knipp and colleagues (2013) found significant
improvement in TA-TAVI participants on MMSE and Digit Span Backwards between
the postoperative evaluation and at the three month follow-up. The improvement at three
months was not significantly different from baseline (Knipp et al., 2013). The present
study included other measures of mental control (e.g., VSAT, Trailmaking Test, Stroop
Word-Color) with Digit Span Backward in an effort to observe nuanced changes in
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complex attention. The lack of significance at follow-up supports that previously
observed changes in mental control are transient in nature.
No significant changes were found in processing speed measures (RBANS
Coding, Stroop Word, Stroop Color, Trailmaking Test A). Prior to the present study's
outset, no previous TAVI cognitive studies included measures of processing speed. As
processing speed influences performance across cognitive measures, it was important to
rule out changes in processing speed as the underlying mechanism for changes in
complex mental processes. Specifically, given the time limits in fluency tests, improved
processing speed would help account for significant improvement in RBANS Fluency.
The present study's results are consistent with a recent publication in TAVI cognitive
research: Alassar et al. (2015) also failed to find significant improvement in processing
speed following the TAVI and in AVR patients.
Ghanem and colleagues (2013) found a significant improvement on the RBANS
Immediate Memory Index three days postoperative. The improvement did not persist at
the three-month follow-up (Ghanem et al., 2013). The lack of significance on the RBANS
Immediate Memory Index supports the transient nature of improvements found by
Ghanem et al. (2013).
Despite statistically significant changes, the clinical relevance is important to
examine. Using the reliable change index (Jacobson & Truax, 1991), two scores are
determined as significantly different when obtaining the scores by chance (based on a
measure's error) has a less than 5% probability. Reliable change index scores were
calculated for RBANS Language Index, RBANS Fluency, and RBANS Figure Recall
using the following formula: RCI = 1.96(Standard Error of Measurement). The RCI's

	
  
53

	
  

	
  

were calculated using standard error of measurement scores for ages 80-89 (Randolf,
2012), because the age group was most representative of the present study's sample. An
RCI was not calculated for List Recall because Randolf (2012) did not provide a standard
error of measurement. No observed changes in RBANS met criteria for a reliable change.
The difference in pre-post RBANS Language Index was 4.08 points, which fell below the
RCI threshold (RCI = 12.11). On average, the difference in RBANS Fluency was 1.51
words, which fell below the RCI threshold of 4.08. The participants mean score for
Figure Recall was 1.34 points higher after the TAVI, which falls below the RCI threshold
for significant change (RCI = 3.94). Failing to exceed the RCI indicates that the
difference between pre and posttest scores could not be reliably measured based on the
psychometric properties of the RBANS index and subtest scores. The group difference
scores (i.e., RBANS Language Index, Fluency, and Figure Recall) are statistically
significant, but the ability to consistently measure these changes on an individual basis
are unlikely.
The lack of significant cognitive changes is still clinically relevant. Postoperative
cognitive decline (POCD) is a common concern, especially following cardiac surgery.
POCD prevalence rates have varied from 10-60% of patients following CABG, and rates
are typically higher following valve surgery due to increased micro-emboli (Lombard &
Mathew, 2010). The high ischemic injury rates in previous TAVI studies (Arnold et al.,
2010; Rodes-Cabau et al, 2011; Kahlert et al., 2010; Samim et al., 2015) have brought
cognitive implications and functional changes to the forefront of TAVI-related outcome
research.
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Previous studies have shown ischemic injury rates post-TAVI in as high as 90%

of patients (Samim et al., 2015). However, high incidence of ischemia may have been
inflated by follow-up neuroimaging timing with higher rates within one week post
procedure. Alassar and colleagues (2015) found that approximately 1/3 of patients with
initial ischemia resolved at 3 months. Similarly, Kahlert and colleagues (2010) found
80% of acute restricted diffusion detected by DW-MRI following the procedure resolved
at 3 months. The present study found 27% (6 of 22) had ischemic lesions that persisted at
one month. The lesions were generally small and dispersed throughout the brain. No
participants were diagnosed with a stroke following the TAVI; therefore, all lesions were
assumed as clinically silent. However, two participants in the study may have had
neurological changes, which suggests clinically apparent stroke or transient ischemic
attack (TIA). One participant excluded from the MRI protocol, reported transient
unilateral hearing loss that resolved at one month. Another participant that withdrew from
the study before the one month follow-up had a major stroke: occlusion of the middle
cerebral artery (MCA). No other neurological symptoms were reported; however, a
neurological examination was not included in the present study.
Of the six participants with new lesions, only one participant evidenced a
clinically significant decline in overall cognitive function (RBANS Total difference = 23,
RBANS Total score RCI = 7.19). Based on Ghanem and colleagues' (2013) results, group
differences in cognitive performance between participants that experienced new lesions
compared to those without were not anticipated. No significant differences were observed
between persons with lesions and those without, supporting the notion that the majority
of ischemic lesions following TAVI are likely clinically silent. However, only 6
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participants evidenced new ischemia, which likely resulted in insufficient power to detect
even medium to large effect sizes.
Numerous factors potentially influence cognitive function following cardiac
procedures beyond direct cerebral injury. The change in RBANS Total score from pre to
post-TAVI was not significantly predicted using the independent variables procedural
length, STS score, and postoperative mean gradient. Procedure length is an indirect
measure of surgery complexity and previous research indicated longer procedure length
in patients with postoperative cognitive decline (Ghanem, 2013). The STS score, a
routinely used algorithm to predict mortality, represents a summation of medical
conditions and cardiac risk factors. Mean gradient is used to grade the severity of aortic
stenosis (Otto, 2006), and a lower post-TAVI mean gradient represents improved
functioning and blood flow through the aortic valve. Procedure length, mean gradient,
and STS were not predictive of changes in RBANS Total score. Similarly, procedure
length, mean gradient, and STS score failed to significantly predict changes in RBANS
Language Index, RBANS Fluency subtest, RBANS List Recall, and RBANS Figure
Recall.
Quality of life improves following the TAVI procedure. A significant
improvement was observed in the KCCQ, which is consistent with previous TAVI
studies. The KCCQ includes aspects of cardiac symptom severity and activity level.
Improved quality of life may be related to reduced aortic stenosis symptoms (e.g., angina,
shortness of breath, etc.) resulting from successful aortic valve implantation. In addition
to improved KCCQ scores, participants had significantly improved GDS scores. The
improved mood can be attributed to multiple factors. First, as evidenced in the KCCQ,
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reduced symptom severity and improved activity may improve mood. Second, the preTAVI GDS was administered a day before the procedure and temporary distress may
have inflated baseline GDS scores. Some GDS questions relate to future worries (e.g.,
"Are you afraid that something bad is going to happen to you?") and a major medical
procedure may induce distress. Third, a complex relationship exists between
cardiovascular disease, cardiac surgeries, and depression. Depression can increase
incidence for cardiovascular disease (Lett et al., 2004) and stroke (Pan et al., 2011).
Depression with onset later in life may result from the interrelationships between
cardiovascular disease, cerebral injury, and cognitive function (Taylor, Aizenstein, &
Alexopoulos, 2013). White matter hyperintensities (i.e., bright areas on MRIs in the
white matter tracts, as opposed to the cortical gray matter, resulting from neuronal
damage, such as ischemia) are associated with cognitive deficits and onset of late-life
depression (Taylor, Aizenstein, & Alexopoulos, 2013). As the present study's
participants' had mild cognitive decline, as evidenced by actual performance falling
below predicted (WTAR), and multiple vascular risk factors (e.g., coronary artery
disease, hypertension, hyperlipidemia, etc.) a "vascular depression" may have resulted.
Increased perfusion to the brain from improved aortic valve function potentially
influences depressive symptoms. However, future research is needed examining
depression in TAVI patients before making any conclusions.
Prior to the TAVI, seven participants met criteria for frailty and two met criteria
at follow-up. The low prevalence of frailty within the sample limited statistical analyses.
However, patterns in the characteristics of frail participants may inform future research.
The pre-TAVI Total RBANS score for frail participants fell below the overall sample's
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mean RBANS Total score, and the GDS scores appear higher. In future research, use of
cognitive measures and mood symptoms may help further define frailty. In the present
study, two questions from the CES-D were used in meeting criteria for frailty. A
relationship between endorsement on the CES-D questions and higher GDS scores is
anticipated, as both are measures of depression. Lower Total RBANS scores in frail
individuals could be bidirectional. Frail individuals may have a lowered ability to engage
in cognitively demanding tasks. Additionally, cognitive decline may be related to
increased incidence of frailty. Examining cognitive changes in frail TAVI patients in
future research could help further our understanding of the frailty construct and how frail
individuals differ from non-frail patients.
Limitations
A limitation in the present study is high family-wise error rate. Controlling for
family-wise error using Bonferroni or a less conservative Holm step-down procedure for
the dependent t-tests results in only two significant differences (KCCQ, p < .001;
RBANS List Recall, p = 0.001). Given the potential for Type I errors, replication of the
study's results are needed.
Another limitation is low n for both ischemic lesions and frailty. Low n prohibited
using MRI data in regression analyses. Additionally, nonparametric analyses, the MannWhitney U, were used to compare group differences using the neuroimaging data.
Nonparametric tests tend to have lower power than parametric (Howell, 2010). Using
parametric analyses, a larger n would increase the likelihood of meeting a test's
assumptions (e.g., normal distribution).
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Another limitation is the complex medical conditions present in most TAVI

candidates. Multiple chronic medical conditions make distinguishing and isolating
relevant variables difficult. Future studies will likely have similar sample characteristics
because the TAVI remains an alternative procedure for high-risk patients; however,
healthy control group comparisons are needed in future research.
Future Directions
The risk of cerebral injury following TAVI remains a major concern in the TAVI
community, because in recent years many studies published support higher ischemic
injury rates in TAVI patients (Kahlert et al., 2010; Samim et al., 2015). However, a link
between silent ischemia and decreased cognitive or functional ability remains
unsubstantiated (Alassar et al., 2015; Ghanem et al., 2013). Randomized controlled trials
are needed to understand the relationship between TAVI and cognitive performance.
Additionally, using DW-MRI may not provide the best measure of neuronal
injury. Many ischemic lesions resolve on the imaging (Kahert et al., 2010; Alassar et al.,
2015), suggesting that higher rates of ischemia may not result in permanent neuronal
damage. Additionally, baseline MRI brain classification may predict cognitive decline
better than postoperative ischemia lesions (Lund et al., 2005). In the present study, no
significant differences were found between those with new lesions and those without on
cognitive measures using Mann-Whitney U, and that Ghanem and colleagues (2013)
failed to find differences between the groups. Therefore, future research may find other
markers of brain health more useful than new ischemic lesions.
Since the present study found a significant improvement in mood, further research
is needed to explain the change. Specifically, are external factors (i.e., improved quality
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of life, decreased effects of aortic stenosis in daily life, postoperative decreased stress
after surviving a cardiac procedure etc.) or physiological changes (i.e., increased
perfusion to the brain) accounting for the observed mood changes?
Finally, future research may extend the patient selection criteria beyond the
current population (i.e., ineligible for AVR). Given the generally stable cognitive
performance following TAVI (present study; Alassar et al., 2015; Ghenam et al., 2013),
patient's with pre-existing cognitive or neurological disorders that otherwise qualify for
AVR, may have better long term cognitive results with an alternative TAVI procedure.
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